A61K 2039/5252
Inactivated
Official title: {inactivated (killed)}
A61K2039/5252 (Inactivated) appears on 1,109 US grants and 1,508 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,109
- Published applications
- 1,508
- Assignees
- 702
- Inventors
- 2,734
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 9 | 0 |
| 1978 | 5 | 0 |
| 1979 | 3 | 0 |
| 1980 | 2 | 0 |
| 1981 | 5 | 0 |
| 1982 | 5 | 0 |
| 1983 | 1 | 0 |
| 1984 | 6 | 0 |
| 1985 | 13 | 0 |
| 1986 | 5 | 0 |
| 1987 | 15 | 0 |
| 1988 | 7 | 0 |
| 1989 | 3 | 0 |
| 1990 | 2 | 0 |
| 1991 | 7 | 0 |
| 1992 | 6 | 0 |
| 1993 | 6 | 0 |
| 1994 | 2 | 0 |
| 1995 | 4 | 0 |
| 1996 | 9 | 0 |
| 1997 | 17 | 0 |
| 1998 | 19 | 0 |
| 1999 | 17 | 0 |
| 2000 | 19 | 0 |
| 2001 | 11 | 8 |
| 2002 | 22 | 29 |
| 2003 | 17 | 31 |
| 2004 | 14 | 36 |
| 2005 | 13 | 44 |
| 2006 | 12 | 37 |
| 2007 | 27 | 55 |
| 2008 | 28 | 70 |
| 2009 | 26 | 60 |
| 2010 | 38 | 73 |
| 2011 | 37 | 85 |
| 2012 | 22 | 60 |
| 2013 | 30 | 68 |
| 2014 | 44 | 61 |
| 2015 | 47 | 69 |
| 2016 | 47 | 74 |
| 2017 | 73 | 85 |
| 2018 | 65 | 77 |
| 2019 | 60 | 63 |
| 2020 | 60 | 64 |
| 2021 | 52 | 78 |
| 2022 | 35 | 63 |
| 2023 | 39 | 75 |
| 2024 | 44 | 74 |
| 2025 | 33 | 38 |
| 2026 | 22 | 31 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Lipidated FLIPr and uses thereof in vaccine6 Oct 2026US 12,752,003 B2National Health Research Institutes
- Use of membrane inhibitors to enhance vaccine development against enveloped viruses8 Sep 2026US 12,728,161 B2Cornell University
- Method of producing an immunogenic composition7 Jul 2026US 12,673,094 B2Boehringer Ingelheim Animal Health USA Inc.
- M Hyo multivalent vaccine and uses thereof16 Jun 2026US 12,653,876 B2
- N protein epitope mutation marker for preparing epitope deletion-marked vaccine strain of type II porcine reproductive and respiratory syndrome virus (PRRSV) and use thereof19 May 2026US 12,629,411 B2Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences
- Treating a type i interferon upregulation or aberrant il-33 upregulation disease or condition with polyomavirus8 Oct 2026US 2026/0306609 A1The General Hospital Corporation
- Vaccine compositions and methods for control of foot and mouth disease10 Sep 2026US 2026/0263583 A1Indian Council of Agricultural Research
- Formulations and uses thereof20 Aug 2026US 2026/0240766 A1Sartorius Albumedix Limited
- Avian metapneumovirus isolates and immunogenic compositions therefrom20 Aug 2026US 2026/0240983 A1Iowa State University Research Foundation, Inc.
- Fusion protein of ge and gi of varicella-zoster virus and use6 Aug 2026US 2026/0224694 A1
Most cited
By later US patents
- Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site1,449US 7,718,180 B22010
- Viral liposome particle151US 4,261,975 AMerck & Co., Inc. · 1981
- Preservation of viruses124US 5,149,653 AQuadrant Bioresources Limited · 1992
- Process for the production of virus vaccine116US 4,659,569 AKabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo · 1987
- Porcine circovirus and paravovirus vaccine105US 6,217,883 B1Merial Limited · 2001